TY - JOUR
T1 - Evaluation of a newly designed microperforated titanium membrane with beta-tricalcium phosphate for guided bone regeneration in dog mandibles
AU - Hasegawa, Hiroshi
AU - Kaneko, Tetsuharu
AU - Kanno, Chihiro
AU - Endo, Manabu
AU - Akimoto, Tetsuo
AU - Yamazaki, Morio
AU - Kitabatake, Takehiro
AU - Masui, Seiichiro
AU - Ishihata, Hiroshi
AU - Izumi, Kenji
N1 - Funding Information:
The authors would like to offer their heartfelt thanks to the following people who assisted in this project: Dr Kazuo Watanabe, Fukushima Pathology Laboratory; Dr Ryota Kawamata, Radiopraxis Science, Kanagawa Dental University; Dr Mizuki Suto and Dr Yukihiko Sakisaka, Department of Oral Biology, Tohoku University Graduate School of Dentistry; Mr Hidekazu Tanji, Research Promotion Office, Fukushima Medical University Hospital; Mr Toshiro Koizumi and Mr Naoki Miki, Lastech; Mr Akihiro Hayashi, Mr Shun-ichiro Kusaka, Mr Toshinori Takeda, and Masaaki Nihei, Hayashi Seiki Seizou Co., Ltd.; Mr Masamitsu Miyazaki, FELIZ laboratory Co., Ltd.; and Mr Toshitaka Sekioka, Ms Kyoko Saisin, and Mr Tomohisa Takagi, J. Morita Corporation. This study was supported by a grant from the development and testing of innovative medical devices in Fukushima Prefecture, Japan. All of the experimental procedures were approved by the Animal Care and Use Committee of Shin Nippon Biomedical Laboratories (approval number: IACUC714-024). The authors reported no conflicts of interest related to this study.
Publisher Copyright:
© 2019 by Quintessence Publishing Co Inc.
PY - 2019
Y1 - 2019
N2 - This study evaluated the efficacy of newly designed, laser-perforated pure titanium membranes for guided bone regeneration using beta-tricalcium phosphate (β-TCP), and compared them with the existing membrane. Materials and Methods: Bilateral acute lateral ridge defects were created in the mandibles of 12 dogs (four defects per animal), which were then randomly divided into two groups (six dogs each). The twenty-four bone defects in each group were then further divided into five groups. The groups were as follows: (1) F001M0, a prototype membrane without a frame plus β-TCP (n = 5); (2) F001M1, a prototype membrane with a frame plus β-TCP (n = 5); (3) FBS, an existing control membrane plus β-TCP (n = 5); (4) control 1, β-TCP without membrane and with covering flap only (n = 5); and (5) control 2, no treatment (no β-TCP and no membrane) (n = 4). In all groups where β-TCP was used, it was mixed with peripheral blood. The animals were necropsied at 6 or 12 weeks postoperatively (six dogs each), and samples were collected and processed for radiographic, histologic, and histomorphometric analyses. Results: Among the three membrane groups, regenerated tissue and bone volume was greatest in the F001M1 group at both 6 and 12 weeks postoperatively, although differences among groups were not statistically significant. Bone mineral density was similar among the membrane groups. Histologic analysis revealed that immature fibroblasts were present on the laser-perforated portion at 6 weeks, which induced vascularization. In addition, more calcified bone was replaced beneath the prototypes than beneath the FBS membrane at 12 weeks. Histomorphometric analyses revealed that the calcific osseous areas at 12 weeks after surgery were significantly greater in the F001M1 and F001M0 groups than in the FBS group (P = .021, P = .032). Furthermore, the fibrous tissue areas beneath the membrane at 12 weeks postoperatively were significantly smaller in the prototype groups than in the FBS group (P = .02, P = .02). Conclusion: The efficacies of both prototype membranes were not inferior to that of the FBS membrane, indicating that they may facilitate bone regeneration and maturation when β-TCP mixed with autologous blood is employed.
AB - This study evaluated the efficacy of newly designed, laser-perforated pure titanium membranes for guided bone regeneration using beta-tricalcium phosphate (β-TCP), and compared them with the existing membrane. Materials and Methods: Bilateral acute lateral ridge defects were created in the mandibles of 12 dogs (four defects per animal), which were then randomly divided into two groups (six dogs each). The twenty-four bone defects in each group were then further divided into five groups. The groups were as follows: (1) F001M0, a prototype membrane without a frame plus β-TCP (n = 5); (2) F001M1, a prototype membrane with a frame plus β-TCP (n = 5); (3) FBS, an existing control membrane plus β-TCP (n = 5); (4) control 1, β-TCP without membrane and with covering flap only (n = 5); and (5) control 2, no treatment (no β-TCP and no membrane) (n = 4). In all groups where β-TCP was used, it was mixed with peripheral blood. The animals were necropsied at 6 or 12 weeks postoperatively (six dogs each), and samples were collected and processed for radiographic, histologic, and histomorphometric analyses. Results: Among the three membrane groups, regenerated tissue and bone volume was greatest in the F001M1 group at both 6 and 12 weeks postoperatively, although differences among groups were not statistically significant. Bone mineral density was similar among the membrane groups. Histologic analysis revealed that immature fibroblasts were present on the laser-perforated portion at 6 weeks, which induced vascularization. In addition, more calcified bone was replaced beneath the prototypes than beneath the FBS membrane at 12 weeks. Histomorphometric analyses revealed that the calcific osseous areas at 12 weeks after surgery were significantly greater in the F001M1 and F001M0 groups than in the FBS group (P = .021, P = .032). Furthermore, the fibrous tissue areas beneath the membrane at 12 weeks postoperatively were significantly smaller in the prototype groups than in the FBS group (P = .02, P = .02). Conclusion: The efficacies of both prototype membranes were not inferior to that of the FBS membrane, indicating that they may facilitate bone regeneration and maturation when β-TCP mixed with autologous blood is employed.
KW - Barrier membrane
KW - Beta-tricalcium phosphate
KW - Guided bone regeneration
KW - Mandible
KW - Titanium membrane
KW - Ultrafine microperforation
UR - http://www.scopus.com/inward/record.url?scp=85072272946&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85072272946&partnerID=8YFLogxK
U2 - 10.11607/jomi.6776
DO - 10.11607/jomi.6776
M3 - Article
C2 - 31528864
AN - SCOPUS:85072272946
SN - 0882-2786
VL - 34
SP - 1132
EP - 1142
JO - International Journal of Oral and Maxillofacial Implants
JF - International Journal of Oral and Maxillofacial Implants
IS - 5
ER -